Belgium/ Milan, November 3, 2025 — Kokuma, a Belgian biotech startup pioneering next-generation skin tone ingredients, will join eight innovative Belgian companies participating in the Belgium–Lombardy cosmetics business roadshow, organized by AWEX (Wallonia Export-Investment Agency) from November 17–20, 2025.

This initiative connects Belgium and Italy’s beauty ecosystems, fostering new B2B collaborations and highlighting European leadership in cosmetic innovation. The delegation represents a broad spectrum of expertise — from biotech, AI, and regulatory compliance to natural ingredients, plasma technology, and circular bio-based materials — reflecting the strength and diversity of Belgium’s cosmetics and personal care industry.

As part of the program, the Belgian delegation will take part in a private visit to the “Making in Milan” 2025 salon on November 19–20, meeting leading Italian brands, groups, and formulators in the Lombardy region, known as Italy’s “Cosmetic Valley.”

Kokuma will present its two clinically proven, patented active ingredients that redefine the future of skin tone science:

• TONASULIKE-D®, a dual-action brightening ingredient that reduces melanosome transfer and rebalances pigmentation signals, achieving +24 percent brighter skin and –17 percent fewer dark spots in 56 days.
• TONASULIKE-P®, the world’s first UV-free melanin booster, proven to double natural melanin production without sun exposure, delivering a natural, luminous glow.

“After three years of R&D, lab testing, and clinical trials, we are proud to meet with the Italian cosmetic industry,” said Alexandre Jouve, Pharm.D., CEO and Co-founder of Kokuma. “As an agile startup, we offer the full innovation loop: our experts combine AI-driven discovery, advanced testing, and clinical validation (in vitro, ex vivo, and in vivo) to bring next-generation cosmetic actives to market faster, safer, and more effectively. Samples market ready,with client orders open by year-end.”

Kokuma’s biotech innovation integrates AI-powered molecular discovery, in-vitro and clinical validation, and a full-loop R&D-to-market model, enabling brands and formulators to create high-performance products for skincare, hybrid makeup, and beauty formulations suitable for all skin tones

*INCI name: Glucuronyl Glucosyloleanolatel (GGO)

“We are deeply committed to promoting innovation in biotech and supporting local companies like Kokuma. Helping to translate cutting-edge research into innovative solutions is at the heart of our mission,” shared Pascale Delcomminette, CEO of AWEX – Wallonia Export & Investment Agency.

Kokuma’s scientific research has been recognized internationally, including a poster presentation at the IFSCC Congress, reinforcing its position at the intersection of biotech, AI, and cosmetic science.